RecallDepth
Class II Completed

Heparin Sodium 2,000, USP Units, per 1,000 mL (2 USP Units/mL) in 0.9% Sodium Chloride Injection, 1,000 mL bags, a) Case (NDC 0409-7620-59), b) Single Unit (NDC 0409-7620-49), Rx only, Distributed By Hospira, Inc., Lake Forest, IL 60045 USA,

This recall has been completed (originally issued January 11, 2023).

Company
Pfizer Inc.
Recall Initiated
December 29, 2022
Posted
January 11, 2023
Recall Number
D-0097-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
62,088 bags
Firm Location
New York, NY, United States
Official Source
View on FDA website ↗

Reason for Recall

Lack of assurance of sterility: Bags have the potential to leak.

Distribution

Nationwide in the USA.

Lot / Code Info

Lot: 5935283, Exp. 12/01/2023

More recalls by Pfizer Inc.

View all recalls by this company →

Other recent Class II Drug recalls